Physician profile
Ali R Tabassian
NPI 1679535538
$4,451.62
in general payments reported to CMS, 2019-2025
9 companies · $25.33 in 2025
The $25.33 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,872 · 2020: $1,355 · 2022: $64.75 · 2023: $56.33 · 2024: $77.87 · 2025: $25.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $4,067.80 | 2019-2020 | |
| Genentech USA, INC. | $161.48 | 2019-2024 | Vabysmo |
| Genentech, INC. | $72.20 | 2019 | |
| Abbvie INC. | $51.98 | 2023-2025 | Ozurdex |
| Alimera Sciences, INC. | $35.25 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.68 | 2023 | Eylea |
| Novartis Pharmaceuticals Corporation | $20.14 | 2019 | |
| Allergan, INC. | $13.09 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Tabassian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.